Mode
Text Size
Log in / Sign up
N/A Completed N=84 Randomized Double-blind Treatment

Scorpio Posterior Stabilised (PS) vs Scorpio NRG ("Energize") PS - Total Knee Arthroplasty

Arthroplasty, Replacement, Knee
Source: ClinicalTrials.gov NCT02520531 ↗
Enrolled (actual)
84
Serious AEs
27.4%
Results posted
Sep 2019
Primary outcomePrimary: Comparison of Maximum Passive and Active Flexion. — 124.58; 125.14; 126.64; 131.33 degree

Summary

Single-centre, prospective, randomized comparative study to compare the maximum flexion and Chair Raise achievement ratios of the Scorpio PS and and the Scorpio NRG PS. Documentation of all complications.

Outcome Measures

OutcomeResultp-value
PRIMARY
Comparison of Maximum Passive and Active Flexion.
124.58; 125.14; 126.64; 131.33; 1.81; 2.72 —
SECONDARY
Knee Society Score (KSS)
47.65; 49.85; 61.65; 69.63; 67.66; 75.38 —
SECONDARY
Chair Raise Test
26; 30; 34; 37; 39; 39 —
SECONDARY
WOMAC Patient Questionnaire
49.33; 47.63; 26.56; 18.69; 19.95; 20.21 —
SECONDARY
EQ-5D (Euro-Quol 5-Dimension) Patient Questionnaire
0.60; 0.53; 0.76; 0.77; 0.76; 0.78 —

Eligibility Criteria

Inclusion Criteria

  • Patients requiring a primary total knee arthroplasty (TKA)
  • Male and nonpregnant female patients
  • Between 18 and 80 years of age at time of surgery
  • Patients with a diagnosis of osteoarthritis (OA), avascular necrosis (AVN), and not severe posttraumatic arthritis
  • No previous osteosynthesis of the involved knee during the last 12 months
  • Patients who understand the conditions of the study and are wiling to participate for the length of the described follow up
  • Patients who are capable of, and have given, informed consent for participation in the study

Exclusion Criteria

  • Patients requiring revision surgery of a previous implanted total knee system
  • Patients with a diagnosis of severe posttraumatic arthritis (TA) and rheumatoid arthritis (RA)
  • Patients with active infection
  • Patients with malignancy
  • Patients with an immobile hip or ankle arthrodesis
  • Severe obese patients (BMI > 35)
  • Patients with a neurological deficit
  • Previous history of unicompartmental knee arthroplasty or patellar prosthesis
  • Patients with concurrent illnesses which are likely to affect their outcome
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02520531). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search